Abeona Therapeutics Inc., of New York, appointed Brian Pereira executive chair of its board and Shawn Tomasello independent board member.
ADC Therapeutics SA, of Lausanne, Switzerland, appointed Jennifer Creel chief financial officer.
Adverum Biotechnologies Inc., of Redwood City, Calif., appointed Scott Whitcup to its board.
Applied Molecular Transport LLC, of South San Francisco, appointed Shawn Cross chief financial officer and Bittoo Kanwar chief medical officer.
Arch Oncology Inc., of Brisbane, Calif., appointed Julie Hambleton to its board.
Cocrystal Pharma Inc., of Bothell, Wash., appointed Roger Kornberg to its board.
Geneuro SA, of Geneva, appointed David Leppert chief medical officer.
Hemostemix Inc., of Calgary, Alberta, appointed Timothy C. Chang to its board of advisers.
Kineta Inc., of Seattle, appointed Martin Cheever, Lisa Coussens, Michael A. Curran, Mark Frohlich, Patricia LoRusso and Mark Middleton to its scientific advisory board.
Nellone Therapeutics Inc., of Knoxville, Tenn., appointed William A. Malkes CEO.
Oculis SA, of Lausanne, Switzerland, appointed Frédéric Pilotaz vice president of technology and pharmaceutical sciences.
Outlook Therapeutics Inc., of Cranbury, N.J., appointed Gerd Auffarth and Julian Gangolli to its board.
Rockwell Medical Inc., of Wixom, Mich., appointed Russell H. Ellison president and CEO.
Sangamo Therapeutics Inc., of Brisbane, Calif., appointed Mark McClung executive vice president and chief business officer.